Cocaine and opioid use during pregnancy: Prevalence and management

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 1, 2008, Pages 59-65

  Bhuvaneswar, Chaya G ^a,b   Chang, Grace ^c,d   Epstein, Lucy A ^e   Stern, Theodore A ^d,f,g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d Department of Psychiatry

^e Columbia University College of Physicians and Surgeons ^*

^f Psychiatric Consultation Service

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE DEPENDENCE; HEALTH CARE POLICY; HUMAN; NOTE; OPIATE ADDICTION; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREVALENCE; PSYCHOLOGICAL ASPECT; SCREENING;

EID: 45849124930     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v10n0110     Document Type: Note

References (70)

1. US Dept Health Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2005 National Survey on Drug Use and Health: National Findings. Rockville, Md: US Dept Health Human Services; 2006. Available at: http://oas.samhsa.gov/nsduh/2k5nsduh/ 2k5Results.pdf. Accessed Nov 17, 2007
2. US Dept Health Human Services, Office of National Drug Control Policy. What America's Users Spend on Drugs, 1999-2002. Rockville, Md: US Dept Health Human Services; 2003. Available at: http://www.whitehousedrugpolicy.gov/ publications/drugfact/american_users_spend2002/. Accessed Nov 17, 2007
3. US Dept Health Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. National Household Survey on Drug Abuse, 1994. Rockville, Md: US Dept Health Human Services; 1995. Available at http://webapp.icpsr.umich.edu/cocoon/SAMHDA-STUDY/06949.xml. Accessed Nov 17, 2007
4. Ostrea EM, Brady M, Gause S, et al. Drug screening of newborns by meconium analysis: a large scale prospective epidemiologic study. Pediatrics 1992;89:107-113
5. Nair P, Rothblum S, Hebel R. Neonatal outcome in infants with evidence of fetal exposure to opiates, cocaine, and cannabinoids. Clin Pediatr (Phila) 1994;33:280-285
6. Osterloh JD, Lee BL. Urine drug screening in mothers and newborns. Am J Dis Child 1989;143:791-793
7. US National Institutes of Health, National Institutes on Drug Abuse. NIDA Survey Provides First National Data on Drug Use During Pregnancy. National Pregnancy and Health Survey, 1992. Bethesda, Md: US National Institutes of Health; 1995. Available at: http://www.drugabuse.gov/NIDA_Notes/NNVOl10N1/ NIDASurvey.html. Accessed Nov 17, 2007
8. Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol 2003;101:374-379
9. US Dept Health Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Substance use among pregnant women during 1999 and 2000. The National Household Survey on Drug Abuse Report. Rockville, Md: US Dept of Health Human Services; 2002. Available at: http://www.oas.samhsa.gov/2k2/preg/preg.htm. Accessed Nov 17, 2007
10. Corman H, Noonan K, Reichman NE, et al. Demand for illicit drugs among pregnant women. Adv Health Econ Health Serv Res 2005;16:41-60
11. Zun LS, Downey L, Rosen J. Who are the young victims of violence? Pediatr Emerg Care 2005;21:568-573
12. Little BB, Gilstrap LC, Cunningham FG. Teratology, drugs and medications. In: Cunningham G, Gant N, Leveno K, et al, eds. Williams Obstetrics. 21st ed. New York, NY: The McGraw Hill Companies; 2001:1005-1031
13. Yonkers K, Little B, eds. Management of Psychiatric Disorders in Pregnancy. London, England: Arnold Publishers; 2001:228-235
14. Silverstein JH, Rieders MF, McMullin M, et al. An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesth Analg 1993;76:618-621
15. Haley N, Roy R, Leclerc P, et al. Characteristics of adolescent street youth with a history of pregnancy. J Pediatr Adolesc Gynecol 2004;17:313-320
16. Birchfield M, Scully J, Handler A. Perinatal screening for illicit drugs: policies in hospitals in a large metropolitan area. J Perinatol 1995;15:208-214
17. Annas GJ. Testing poor pregnant patients for cocaine: physicians as police investigators. N Eng J Med 2001;344(22):1729-1732
18. Burkett G, Yasin SY, Palow D, et al. Patterns of cocaine binging: effect on pregnancy. Am J Obstet Gynecol 1994;171:372-378
19. Ovelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108(4):1005-1016
20. Roberts R, Dinsmore W. Sexually transmitted diseases in pregnancy. Br J Hosp Med 1992;47:674-679
21. Andrus S, Bernosky K, Marshall S. Psychomotor Stimulants. Primer on Drug Addiction. Buffalo, NY: Research Unit, University of Buffalo, State University of New York; 2007. Available at: http://www.wings.buffalo.edu/aru/PSY402C07.ppt. Accessed Nov 17, 2007
22. Gatof D, Albert RK. Bilateral thumb burns leading to the diagnosis of crack lung. Chest 2002;121:289-291
23. O'Donnell AE, Mappin FG, Sebo TJ, et al. Interstitial pneumonitis associated with "crack" cocaine abuse. Chest 1991;100:1155-1157
24. Sharma P, Thapa L. Acute pyelonephritis in pregnancy: a retrospective study. Aust N Z J Obstet Gynaecol 2007;47(4):313-315
25. Blaho K, Winbery S, Park L. Cocaine metabolism in hyperthermic patients with excited delirium. J Clin Forensic Med 2000;7:71-76
26. Storen EC, Wijdicks EF, Crum BA, et al. Moyamoya-like vasculopathy from cocaine dependency. Am J Neuroradiol 2000;21:1008-1010
27. Little BB, Snell LM. Brain growth among fetuses exposed to cocaine in utero: asymmetric growth retardation. Obstet and Gynecol 1991;77:361-364
28. Williams JH, Ross L. Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review. Eur Child Adolesc Psychiatry 2007;16:243-253
29. Safra MJ, Oakley GP Jr. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975;2:478-480
30. Mehanny SZ, Abdel-Rahman MS, Ahmed YY. Teratogenic effect of cocaine and diazepam in CF1 mice. Teratology 1991;43:11-17
31. Paine TA, Jackman SL, Olmstead MC. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. Behav Pharmacol 2002;13:511-523
32. Resnick RB, Resnick EB. Cocaine abuse and its treatment. Psychiatr Clin North Am 1984;7:713-728
33. Levin FR, Evans SM, McDowell DM, et al. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis 2002;21:1-16
34. Kleber HD. Pharmacologic treatments for heroin and cocaine dependence. Am J Addict 2003;12(suppl 2):S5-S18
35. Luty J, Nikolau V, Beam J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat 2003;24:363-367
36. Hulse GK, Milne E, English DR, et al. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998;93:1033-1042
37. LoVecchio F, Pizon A, Riley B, et al. Onset of symptoms after methadone overdose. Am J Emerg Med 2007;25:57-59
38. Farrell M. Opiate withdrawal. Addiction 1994;89:1471-1475
39. Zuspan FP, Gumpel JA, Mejia-Zelaya A, et al. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43-46
40. Rementeria JL, Nunag NN. Narcotic withdrawal in pregnancy: still-birth incidence with a case report. Am J Obstet Gynecol 1973;116:1152-1156
41. Kusche C. Managing drug withdrawal in the newborn infant. Semin Fetal Neonatal Med 2007;12:127-133
42. Wolff K, Boys A, Rostami-Hodjegan A, et al. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005;61:763-768
43. McCarthy JJ, Leamon MH, Parr MS, et al. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 2005;193:606-610
44. Lacroix I, Berrebi A, Chaumerliac C, et al. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction 2004;99(2):209-214
45. Kashiwagi M, Arlettaz R, Lauper U, et al. Methadone maintenance program in a Swiss perinatal center, 1: management and outcome of 89 pregnancies. Acta Obstetet Gynecol Scand 2005;84:140-144
46. Johnson K, Gerada C, Greenough A. Substance misuse during pregnancy. Br J Psychiatry 2003;183:187-189
47. Rich JD, Boutwell AE, Shield DC, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health 2005;82:411-419
48. Hunt DE, Lipton LS, Goldsmith DS, et al. It takes your heart: the image of methadone maintenance in the addict world and its effect on recruitment into treatment. Int J Addict 1985;20:1751-1771
49. Latowsky M. Methadone death, dosage and torsade de pointes: risk-benefit policy implications. J Psychoactive Drugs 2006;38:513-520
50. Rosenblum A, Magura S, Joseph H. Ambivalence toward methadone treatment among intravenous drug users. J Psychoactive Drugs 1991;23:21-27
51. Chang G, Carroll KM, Behr HM, et al. Improving treatment outcome in pregnant opiate-dependent women. J Subst Abuse Treat 1992;9:327-330
52. Suffet F, Brotman R. A comprehensive care program for the pregnant addict: obstetrical, neonatal and child development outcomes. Int J Addict 1984;19:199-219
53. DePetrillo PB, Rice JM. Methadone dosing and pregnancy: impact on program compliance. Int J Addict 1995;30:207-217
54. Auriacombe M, Fatséas M, Dubernet J, et al. French field experience with buprenorphine. Am J Addict 2004;13(suppl 1):S17-S28
55. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double blind, double dummy comparison study. Addiction 2006;101:275-281
56. Auriacombe M, Affelou S, Lavignasse P, et al. Pregnancy, abortion and delivery in a cohort of heroin dependent patients treated with drug substitution (methadone and buprenorphine) in Aquitaine. Presse Med 1999;28:177
57. Kahila H, Saisto T, Kivitie-Kallio S, et al. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome. Acta Obstet Gynecol Scand 2007;86:185-190
58. Hulse GK, O'Neill G, Pereira C, et al. Obstetric and neonatal outcomes associated with maternal naltrexone exposure. Aust N Z J Obstet Gynaecol 2001;41:424-428
59. Hulse G, O'Neill G. Using naltrexone implants in the management of the pregnant heroin user. Aust N Z J Obstet Gynaecol 2002;42:569-573
60. Shieh C, Kravitz M. Maternal-fetal attachment in pregnant women who use illicit drugs. J Obstet Gynecol Neonatal Nurs 2002;31:156-164
61. Kovalesky A, Flagler S. Child placement issues of women with addictions. J Obstet Gynecol Neonatal Nurs 1997;26:585-592
62. Kumper KL, Fowler MA. Parenting skills and family support programs for drug-abusing mothers. Semin Fetal Neonatal Med 2007;12:134-142
63. Velez ML, Jansson LM, Montoya ID, et al. Parenting knowledge among substance abusing women in treatment. J Subst Abuse Treat 2004;27:215-222
64. Rayburn W, Aronow R, DeLancey B, et al. Drug overdose during pregnancy: an overview from a metropolitan poison control center. Obstet Gynecol 1984;64:611-614
65. Sein Anand J, Chodorowski Z, Ciechanowicz R, et al. Acute suicidal self-poisonings during pregnancy. Przegl Lek 2005;62:434-435
66. Fitzsimons HE, Tuten M, Vaidya V, et al. Mood disorders affect drug treatment success of drug-dependent pregnant women. J Subst Abuse Treat 2007;32(1):19-25
67. The Lindesmith Library Database Search. Drug Policy Alliance Online. Available at: http://library.soros.org/lindesmith.html. Accessed November 29, 2007
68. Chavkin W, Breitbart V, Elman D, et al. National survey of the states: policies and practices regarding drug-using pregnant women. Am J Public Health 1998;88:117-119
69. Chasnoff IJ, Landress HJ, Barrett ME, et al. The prevalence of illicit-drug or alcohol use during pregnancy and discrepancies in mandatory reporting in Pinellas County, Florida. N Engl J Med 1990;322:1202-1206
70. Society for Maternal Fetal Medicine. Physician Locator and FAQs. Washington, DC: Society for Maternal Fetal Medicine, 2007. Available at: http://www.smfm.org. Accessed Nov 17, 2007